# Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure

> **NCT03063697** · — · UNKNOWN · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 20000 (estimated)

## Conditions studied

- Essential Hypertension
- Chronic Stable Angina
- Congestive Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03063697
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 20000 (ESTIMATED)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03063697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03063697, "Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03063697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*